United States · FDA National Drug Code directory
Amlodipine Besylate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-732_4f9271e4-d2e6-4456-a890-69d43dcf7496
- Product NDC
- 71610-732
- Form
- TABLET
- Composition / generic term
- Amlodipine Besylate
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221001
- Source listing expiry
- 20261231
Source-listed ingredients
- AMLODIPINE BESYLATE — 2.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 15 TABLET in 1 BOTTLE (71610-732-15) · 71610-732-15
- 30 TABLET in 1 BOTTLE (71610-732-30) · 71610-732-30
- 45 TABLET in 1 BOTTLE (71610-732-45) · 71610-732-45
- 60 TABLET in 1 BOTTLE (71610-732-53) · 71610-732-53
- 90 TABLET in 1 BOTTLE (71610-732-60) · 71610-732-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →